| Price | 13,820.00p on 21-11-2025 at 17:35:13 |
|---|---|
| Change | 170.00p 1.25% |
| Buy | 13,838.00p |
| Sell | 13,832.00p |
| Last Trade: | Unknown 45.00 at 13,652.18713p |
| Day's Volume: | 3,044,640 |
| Last Close: | 13,820.00p |
| Open: | 13,508.00p |
| ISIN: | GB0009895292 |
| Day's Range | 13,508.00p - 13,836.00p |
| 52wk Range: | 9,574.00p - 13,884.00p |
| Market Capitalisation: | £214.25b |
| VWAP: | 13,663.67053p |
| Shares in Issue: | 1.55b |
Astrazeneca (AZN) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 45 | 13,652.18713p | Currency Conversion Negotiated Trade OTC Trade |
17:33:02 - 21-Nov-25 |
| Unknown* | 147 | 13,656.12774p | Currency Conversion Negotiated Trade OTC Trade |
17:32:49 - 21-Nov-25 |
| Sell* | 80 | 13,820.00p | SI Trade Suspected SELL Trade |
16:49:35 - 21-Nov-25 |
| Sell* | 1,083 | 13,820.00p | Negotiated Trade |
16:37:44 - 21-Nov-25 |
| Sell* | 13 | 13,820.00p | Automatic Execution |
16:36:12 - 21-Nov-25 |
| Buy* | 429 | 13,820.00p | SI Trade |
16:35:08 - 21-Nov-25 |
| Buy* | 820 | 13,820.00p | SI Trade |
16:35:08 - 21-Nov-25 |
| Buy* | 1 | 13,820.00p | SI Trade |
16:35:08 - 21-Nov-25 |
| Buy* | 41 | 13,820.00p | SI Trade |
16:35:08 - 21-Nov-25 |
| Buy* | 17 | 13,820.00p | SI Trade |
16:35:08 - 21-Nov-25 |
Astrazeneca (AZN) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 20th Nov 2025 7:00 am | RNS | Koselugo (selumetinib) approved in the US |
| 17th Nov 2025 3:00 pm | RNS | Holding(s) in Company |
| 14th Nov 2025 11:00 am | RNS | Director/PDMR Shareholding |
| 10th Nov 2025 3:00 pm | RNS | Director/PDMR Shareholding |
| 6th Nov 2025 7:00 am | RNS | 9M and Q3 2025 results |
| 3rd Nov 2025 4:00 pm | RNS | Result of General Meeting |
| 3rd Nov 2025 3:00 pm | RNS | Total Voting Rights |
| 28th Oct 2025 7:05 am | RNS | Director Declaration |
| 28th Oct 2025 7:00 am | RNS | Koselugo (selumetinib) approved in the EU |
| 22nd Oct 2025 7:00 am | RNS | Tezspire Approved in EU for CRSwNP |
